Type 2 & other diabetes

The impact of population-level HbA1c screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis

DiabetologiaPublished Population-based cohort study

An erratum to this article was published (Diabetologia, Aug 2023 ↗)

Authors' conclusion

Our population-based study shows that HbA1c screening in adults aged 40-70 years can reduce the time to diabetes diagnosis by a median of 2.2 years compared with routine clinical care. The findings support the use of HbA1c screening to reduce the time for which individuals are living with undiagnosed diabetes.

Study context

Population
UK Biobank participants aged 40–70 years with HbA1c measured at enrolment (not fed back to participants/clinicians) and linked primary and secondary healthcare data; undiagnosed diabetes = enrolment HbA1c ≥48 mmol/mol (≥6.5%) without diabetes diagnosis166,846 without diabetes diagnosis
Participants
179,923 participants
Outcome
Time from enrolment HbA1c measurement to subsequent clinical diabetes diagnosis in those with undiagnosed diabetes
Follow-up
Up to 10 years
Methodological detailsUK Biobank, linked primary and secondary healthcare data, Kaplan-Meier analysis, Cox regression
  • UK Biobank
  • Linked primary and secondary healthcare data
  • Kaplan-Meier analysis
  • Cox regression

Main finding

As reported in the abstract

Time to clinical diagnosis in undiagnosed diabetes

Median time to clinical diagnosis

2.2 years

Median HbA1c at clinical diagnosis

58.2 mmol/mol (IQR 51.0-80.0) (7.5% [6.8-9.5])

Observational data: associations, not effects.

Further findings

Prevalence of undiagnosed diabetes at enrolment

Undiagnosed diabetes among participants without diabetes diagnosis
1.0% (1703/166,846)
Median HbA1c at enrolment
51.3 mmol/mol (IQR 49.1-57.2) (6.8% [6.6-7.4])
Additional diabetes cases relative to the 13,077 with a diagnosis
13.0%
Pre-existing diabetes diagnosis
13,077, 7.3%

Factors associated with delayed diagnosis

Female participants with lower HbA1c and BMI at enrolment experienced the longest delay to clinical diagnosis

Original publication

The impact of population-level HbA1c screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis. Diabetologia. Published 22 November 2022. doi:10.1007/s00125-022-05824-0

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.